{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T01:34:22Z","timestamp":1649122462403},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5,1]]},"DOI":"10.2146\/ajhp150655","type":"journal-article","created":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T06:13:01Z","timestamp":1461132781000},"page":"e229-e237","source":"Crossref","is-referenced-by-count":1,"title":["What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation?"],"prefix":"10.1093","volume":"73","author":[{"given":"Jade E.","family":"Basaraba","sequence":"first","affiliation":[{"name":"Mazankowski Alberta Heart Institute, Alberta Health Services, Edmonton, Canada, and Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arden R.","family":"Barry","sequence":"additional","affiliation":[{"name":"Lower Mainland Pharmacy Services, Chilliwack, Canada, and Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041102511673700_b1-073e229","first-page":"e29","article-title":"Heart disease and stroke statistics\u20142015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041102511673700_b2-073e229","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O\u2019Gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041102511673700_b3-073e229","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041102511673700_b4-073e229","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041102511673700_b5-073e229","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jacc.2007.06.029","article-title":"Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial","volume":"50","author":"Morice","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041102511673700_b6-073e229","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2015.04.017","article-title":"Long-term safety of drug-eluting and bare-metal stents","volume":"65","author":"Palmerini","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041102511673700_b7-073e229","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.cjca.2013.07.001","article-title":"Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy","volume":"29","author":"Tanguay","year":"2013","journal-title":"Can J Cardiol"},{"key":"key\n\t\t\t\t2019041102511673700_b8-073e229","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019041102511673700_b9-073e229","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041102511673700_b10-073e229","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/hrt.2011.227272","article-title":"Association of cytochrome P450 2C19*2 polymorphism with clopidogrel response variability and cardiovascular events in Koreans treated with drug-eluting stents","volume":"98","author":"Oh","year":"2012","journal-title":"Heart"},{"key":"key\n\t\t\t\t2019041102511673700_b11-073e229","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041102511673700_b12-073e229","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041102511673700_b13-073e229","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.jacc.2014.09.008","article-title":"Second-generation drug-eluting stent implantation followed by 6-versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial","volume":"64","author":"Colombo","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041102511673700_b14-073e229","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/eurheartj\/ehu523","article-title":"ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting","volume":"36","author":"Schulz-Sch\u00fcpke","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019041102511673700_b15-073e229","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/FJC.0000000000000088","article-title":"Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a meta-analysis of 3 randomized controlled trials","volume":"64","author":"Liu","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t2019041102511673700_b16-073e229","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.111.071589","article-title":"Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial","volume":"125","author":"Valgimigli","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041102511673700_b17-073e229","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2014.11.008","article-title":"6-versus 24-month dual anti-platelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial","volume":"65","author":"Giland","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041102511673700_b18-073e229","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2014.12.046","article-title":"Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis","volume":"65","author":"Palmerini","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041102511673700_b19-073e229","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ccd.25520","article-title":"Shorter (\u22646 months) versus longer (\u226512 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials","volume":"85","author":"Pandit","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"key\n\t\t\t\t2019041102511673700_b20-073e229","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.amjcard.2014.04.035","article-title":"Meta-analysis of randomized clinical trials comparing short-term versus long-term dual antiplatelet therapy following drug-eluting stents","volume":"114","author":"El-Hayek","year":"2014","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019041102511673700_b21-073e229","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jacc.2014.06.1158","article-title":"Short versus long duration of DAPT after DES implantation: a meta-analysis","volume":"64","author":"Stefanini","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041102511673700_b22-073e229","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMoa1001266","article-title":"Duration of dual antiplatelet therapy after implantation of drug-eluting stents","volume":"362","author":"Park","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041102511673700_b23-073e229","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.113.003303","article-title":"Optimal duration of dual anti-platelet therapy after drug-eluting stent implantation: a randomized, controlled trial","volume":"129","author":"Lee","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041102511673700_b24-073e229","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(14)60612-7","article-title":"Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARTIC-Interruption): a randomised trial","volume":"384","author":"Collet","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041102511673700_b25-073e229","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual anti-platelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041102511673700_b26-073e229","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041102511673700_b27-073e229","first-page":"365","article-title":"Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial","volume":"37","author":"Helft","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019041102511673700_b28-073e229","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jacc.2015.01.039","article-title":"Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials","volume":"65","author":"Giustino","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041102511673700_b29-073e229","doi-asserted-by":"crossref","first-page":"h1618","DOI":"10.1136\/bmj.h1618","article-title":"Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: a meta-analysis of randomised controlled trials","volume":"350","author":"Navarese","year":"2015","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041102511673700_b30-073e229","doi-asserted-by":"crossref","first-page":"118","DOI":"10.7326\/M15-0083","article-title":"Longer versus shorter duration dual-antiplatelet therapy after drug-eluting stent placement","volume":"163","author":"Spencer","year":"2015","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041102511673700_b31-073e229","unstructured":"Food and Drug Administration. Plavix (clopidogrel): drug safety communication\u2014long-term treatment does not change risk of death (November06, 2015). www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm471531.htm (accessed 2016 Feb 22)."},{"key":"key\n\t\t\t\t2019041102511673700_b32-073e229","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA guideline focused update on duration of dual anti-platelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 ACC\/AHA guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery","author":"Levine","year":"2016","journal-title":"Circulation"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/73\/9\/e229\/28335247\/ajhp0e229.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T17:50:50Z","timestamp":1567792250000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/73\/9\/e229\/5101674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,1]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,5,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp150655","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,5,1]]},"published":{"date-parts":[[2016,5,1]]}}}